THE THROGMORTON TRUST PLC
All information is at 31 October 2010 and unaudited.
Performance at month end is calculated on a cum income basis
One Three One Three
Month Months Year Years
Net asset value# 6.0% 22.3% 49.2% 12.7%
Net asset value^ 6.0% 22.3% 49.4% 7.6%
Net asset value^^ 5.1% 18.4% 40.3% 1.0%
Share price 9.9% 19.8% 51.2% 8.1%
Subscription share price 72.2% 200.0% n/a n/a
HGSC plus AIM (ex Inv Cos) 3.6% 12.5% 23.4% -8.9%
# NAV prior to costs of repaying the debentures early
^ NAV after costs of repaying the debentures early - undiluted
^^ NAV after costs of repaying debentures early - diluted
Sources: BlackRock and Datastream
At month end
Net asset value capital only: 206.89p
Net asset value incl. income: 209.54p
Share price: 166.50p
Discount to capital only NAV: 19.5%
Subscription share price: 23.25p
Net yield: 1.6% *
Total assets: £129.3m **
Gearing: Nil
Ordinary shares in issue: 58,367,192 ***
Subscription shares in issue: 14,763,134
*Calculated using prior year interim and final dividends paid.
**Includes current year revenue.
***Excluding 7,400,000 shares held in treasury.
Ten Largest Sector
Weightings % of Total Assets
Software & Computer Services 10.3
Mining 10.1
Electronic & Electrical Equipment 9.5
Oil & Gas Producers 8.6
Support Services 7.8
Financial Services 7.2
Industrial Engineering 6.6
Media 4.8
Pharmaceutical & Biotechnology 4.5
Technology Hardware & Equipment 4.4
----
Total 73.8
====
Ten Largest Equity Investments (in alphabetical order)~
Company
Abcam
Aveva Group
City of London Investment Group
Domino Printing Sciences
Eastern Platinum
Fidessa
Hutchison China Meditech
IQE
Spirax-Sarco Engineering
Western Coal
Commenting on the markets, Mike Prentis and Richard Plackett, representing the
Investment Manager noted:
During October the Company's NAV per share rose by 6.0% on a cum income basis;
this was ahead of the benchmark which rose by 3.6%. The FTSE 100 Index rose by
2.3%.
Our outperformance was mainly derived from stock selection but asset allocation
also contributed to outperformance. The CFD portfolio again added value.
From a stock point of view two holdings contributed more than 0.25% each to
relative outperformance, Hutchison China Meditech and City of London Investment
Group. Hutchison China Meditech had been our one poor performer in September.
There was no newsflow in respect of the stock during September and October but
the share price did make up for its weak performance in September. City of
London Investment Group announced that assets under management had increased by
30% since its 31 May year end, helped by stronger emerging markets indices. It
also moved its listing from AIM to the Official List.
Pleasingly no one holding had a significant negative impact on the relative
performance of the portfolio during the month.
We sold our holding in Bluebay Asset Management following a bid by Royal Bank
of Canada. Our holding in Bluebay had only been acquired in September, so we
were very surprised to see a bid emerge. We also sold our holding in Intec
Telecom which had received a bid from CSG of the US.
We took new holdings in TT Electronics and New Britain Palm Oil. TT Electronics
supplies sensors and other components mainly into automotive and industrial
markets globally. New management have reshaped the business and are driving up
margins from low levels. We feel the business is still undervalued;
and it is trading well. New Britain Palm Oil is a significant producer of palm
oil based in the Pacific. We had no previous exposure to soft commodities and
with the palm oil price moving up sharply, as have many soft commodity prices,
we felt it appropriate to make a small investment.
Latest information is available by typing www.blackrock.co.uk/its on the
internet, "BLRKINDEX" on Reuters, "BLRK" on Bloomberg or "8800" on Topic 3 (ICV
terminal).
15 November 2010
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.